(Q36771631)

16 August 2017

1 reference

title

Aminoglutethimide: a "side-effect" turned to therapeutic advantage (English)

1 reference

16 August 2017

Hughss SW

1

1 reference

16 August 2017

Burley DM

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 July 1970

1 reference

Postgraduate Medical Journal

16 August 2017

1 reference

16 August 2017

46

1 reference

16 August 2017

537

1 reference

16 August 2017

409-416

1 reference

EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

DIAGNOSTICALLY CONFUSING COMPLICATIONS OF DIPHENYLHYDANTOIN THERAPY. A REVIEW.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Diphenylhydantoin (dilantin) after 20 years; a review with re-emphasis by treatment of 84 patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Pharmacologic alteration of steroid hormone functions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Inhibitors of adrenal cortical function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Aminoglutethimide in the treatment of epilepsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

[Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland]

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Elipten: A clinical evaluation of a new anticonvulsant. Preliminary report

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Treatment of advanced malignancy and Cushing's syndrome with DDD.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

Effects of amino-glutethimide on adrenal function in man.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2467063

One thousand cases of late onset epilepsy

5 September 2018

1 reference

12 December 2020

Elipten in the treatment of organic epilepsy

1 reference

12 December 2020

Aminoglutethimide (Elipten® CIBA)—A New Inhibitor of Steroid Biosynthesis

1 reference

12 December 2020

Antithyroid and antiadrenocortical activity of aminoglutethimide

1 reference

12 December 2020

Effect of an adrenal inhibitor in hypertensive patients with suppressed renin

1 reference

12 December 2020

Suppression of tumorous adrenal hyperfunction by aminoglutethimide

1 reference

12 December 2020

Hypertrichosis occurring in association with dilantin therapy

1 reference

12 December 2020

Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma

1 reference

12 December 2020

Treatment of epilepsy with diphenylhydantoin sodium (dilantin sodium)

1 reference

12 December 2020

Lack of glutethimide effect of adrenal

1 reference

12 December 2020

[Effects of a new derivative of glutaric imide (16038) on strychnine-induced cortical epilepsy]

1 reference

12 December 2020

Efficacy of amino-glutethimide in the ectopic ACTH syndrome

1 reference

12 December 2020

Aminoglutethimide Inhibition of Adrenal Desmolase Activity

1 reference

12 December 2020

Ovarian dysfunction associated with an anticonvulsant drug

1 reference

12 December 2020

A clinical trial with a new anticonvulsant drug, alpha-(p-aminophenyl)-alpha-ethyl glutarimide preparation 16038 (Ciba)

1 reference

12 December 2020

[A new anticonvulsant: the preparation Ciba 16-0-38 or elipten. Its importance in refractory epilepsy.]

1 reference

12 December 2020

[A new anticonvulsant, elipten; a preliminary report.]

1 reference

12 December 2020

Changes in the ovary of rats following application of aminoglutethimide (Elipten-CIBA)

1 reference

12 December 2020

The metabolism of glutethimide (Doriden®)

1 reference

12 December 2020

Effects of Aminoglutethimide Upon Adrenal Function and Cortisol Metabolism in Cushing's Syndrome

1 reference

12 December 2020

Goitrous hypothyroidism induced by amino-glutethimide, anticonvulsant drug

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.46.537.409

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

4920933

1 reference